{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T03:47:12Z","timestamp":1782618432664,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T00:00:00Z","timestamp":1349136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2407-12-440","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T10:14:09Z","timestamp":1349172849000},"source":"Crossref","is-referenced-by-count":18,"title":["Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Sepideh","family":"Saadatmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel J T","family":"Rutgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RobAEM","family":"Tollenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermien M","family":"Zonderland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MargreetGEM","family":"Ausems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KristienBMI","family":"Keymeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet S","family":"Schlooz-Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linetta B","family":"Koppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline A M","family":"Heijnsdijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Seynaeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C","family":"Oosterwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge-Marie","family":"Obdeijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine M A","family":"Tilanus-Linthorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,2]]},"reference":[{"issue":"3","key":"3332_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","volume":"73","author":"EB Claus","year":"1994","unstructured":"Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer. 1994, 73 (3): 643-651. 10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5.","journal-title":"Cancer"},{"issue":"1","key":"3332_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.bjc.6605421","volume":"102","author":"A Brandt","year":"2010","unstructured":"Brandt A, Bermejo JL, Sundquist J, Hemminki K: Age of onset in familial breast cancer as background data for medical surveillance. Br J Cancer. 2010, 102 (1): 42-47. 10.1038\/sj.bjc.6605421.","journal-title":"Br J Cancer"},{"issue":"4","key":"3332_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10689-006-7851-3","volume":"5","author":"S Margolin","year":"2006","unstructured":"Margolin S, Johansson H, Rutqvist LE, Lindblom A, Fornander T: Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County. Fam Cancer. 2006, 5 (4): 309-321. 10.1007\/s10689-006-7851-3.","journal-title":"Fam Cancer"},{"issue":"3","key":"3332_CR4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ijc.11226","volume":"106","author":"M Sant","year":"2003","unstructured":"Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J, et al: Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 2003, 106 (3): 416-422. 10.1002\/ijc.11226.","journal-title":"Int J Cancer"},{"issue":"2","key":"3332_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/ijc.26394","volume":"131","author":"A Maurice","year":"2012","unstructured":"Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A: Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: Further evidence of benefit. Int J Cancer. 2012, 131 (2): 417-425. 10.1002\/ijc.26394.","journal-title":"Int J Cancer"},{"issue":"12","key":"3332_CR6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1470-2045(10)70263-1","volume":"11","author":"teams FHc","year":"2010","unstructured":"teams FHc: Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol. 2010, 11 (12): 1127-1134.","journal-title":"Lancet Oncol"},{"issue":"4","key":"3332_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0959-8049(99)00337-8","volume":"36","author":"MM Tilanus-Linthorst","year":"2000","unstructured":"Tilanus-Linthorst MM, Bartels CC, Obdeijn AI, Oudkerk M: Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer. 2000, 36 (4): 514-519. 10.1016\/S0959-8049(99)00337-8.","journal-title":"Eur J Cancer"},{"issue":"4","key":"3332_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.breast.2007.01.006","volume":"16","author":"AI Hagen","year":"2007","unstructured":"Hagen AI, Kvistad KA, Maehle L, Holmen MM, Aase H, Styr B, Vabo A, Apold J, Skaane P, Moller P: Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast. 2007, 16 (4): 367-374. 10.1016\/j.breast.2007.01.006.","journal-title":"Breast"},{"issue":"9","key":"3332_CR9","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1200\/JCO.2009.23.0839","volume":"28","author":"C Kuhl","year":"2010","unstructured":"Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, Konig R, Tombach B, Leutner C, Rieber-Brambs A, Nordhoff D, et al: Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol. 2010, 28 (9): 1450-1457. 10.1200\/JCO.2009.23.0839.","journal-title":"J Clin Oncol"},{"issue":"9473","key":"3332_CR10","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","volume":"365","author":"MO Leach","year":"2005","unstructured":"Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, Gilbert FJ, Griebsch I, Hoff RJ, Kessar P, et al: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005, 365 (9473): 1769-1778.","journal-title":"Lancet"},{"issue":"36","key":"3332_CR11","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","volume":"28","author":"AJ Rijnsburger","year":"2010","unstructured":"Rijnsburger AJ, Obdeijn IM, Kaas R, Tilanus-Linthorst MM, Boetes C, Loo CE, Wasser MN, Bergers E, Kok T, Muller SH, et al: BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. J Clin Oncol. 2010, 28 (36): 5265-5273. 10.1200\/JCO.2009.27.2294.","journal-title":"J Clin Oncol"},{"issue":"11","key":"3332_CR12","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, et al: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004, 292 (11): 1317-1325. 10.1001\/jama.292.11.1317.","journal-title":"JAMA"},{"issue":"2","key":"3332_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.amjsurg.2009.01.010","volume":"198","author":"S van der Velden AP","year":"2009","unstructured":"van der Velden AP S, Schlooz-Vries MS, Boetes C, Wobbes T: Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg. 2009, 198 (2): 262-269. 10.1016\/j.amjsurg.2009.01.010.","journal-title":"Am J Surg"},{"issue":"7","key":"3332_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/sj.bjc.6603356","volume":"95","author":"I Griebsch","year":"2006","unstructured":"Griebsch I, Brown J, Boggis C, Dixon A, Dixon M, Easton D, Eeles R, Evans DG, Gilbert FJ, Hawnaur J, et al: Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer. 2006, 95 (7): 801-810. 10.1038\/sj.bjc.6603356.","journal-title":"Br J Cancer"},{"issue":"3","key":"3332_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiol.09091086","volume":"254","author":"JM Lee","year":"2010","unstructured":"Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS: Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology. 2010, 254 (3): 793-800. 10.1148\/radiol.09091086.","journal-title":"Radiology"},{"issue":"20","key":"3332_CR16","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1001\/jama.295.20.2374","volume":"295","author":"SK Plevritis","year":"2006","unstructured":"Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, Garber AM: Cost-effectiveness of screening BRCA1\/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006, 295 (20): 2374-2384. 10.1001\/jama.295.20.2374.","journal-title":"JAMA"},{"key":"3332_CR17","unstructured":"Richtlijn mammacarcinoom. http:\/\/www.oncoline.nl\/uploaded\/docs\/mammacarcinoom\/mammacdiagscr.pdf ,"},{"issue":"2","key":"3332_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007, 57 (2): 75-89. 10.3322\/canjclin.57.2.75.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3332_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJMe068244","volume":"356","author":"K Kerlikowske","year":"2007","unstructured":"Kerlikowske K: The mammogram that cried Wolfe. N Engl J Med. 2007, 356 (3): 297-300. 10.1056\/NEJMe068244.","journal-title":"N Engl J Med"},{"issue":"3","key":"3332_CR20","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1158\/0008-5472.CAN-05-3368","volume":"66","author":"G Mitchell","year":"2006","unstructured":"Mitchell G, Antoniou AC, Warren R, Peock S, Brown J, Davies R, Mattison J, Cook M, Warsi I, Evans DG, et al: Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res. 2006, 66 (3): 1866-1872. 10.1158\/0008-5472.CAN-05-3368.","journal-title":"Cancer Res"},{"issue":"3","key":"3332_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJMoa062790","volume":"356","author":"NF Boyd","year":"2007","unstructured":"Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, et al: Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007, 356 (3): 227-236. 10.1056\/NEJMoa062790.","journal-title":"N Engl J Med"},{"issue":"6","key":"3332_CR22","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/bcr2447","volume":"11","author":"DJ Thompson","year":"2009","unstructured":"Thompson DJ, Leach MO, Kwan-Lim G, Gayther SA, Ramus SJ, Warsi I, Lennard F, Khazen M, Bryant E, Reed S, et al: Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study. Breast Cancer Res. 2009, 11 (6): R80-10.1186\/bcr2447.","journal-title":"Breast Cancer Res"},{"issue":"13","key":"3332_CR23","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa065447","volume":"356","author":"CD Lehman","year":"2007","unstructured":"Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, Peacock S, Smazal SF, Maki DD, Julian TB, et al: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007, 356 (13): 1295-1303. 10.1056\/NEJMoa065447.","journal-title":"N Engl J Med"},{"issue":"24","key":"3332_CR24","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1158\/1078-0432.CCR-07-0689","volume":"13","author":"MM Tilanus-Linthorst","year":"2007","unstructured":"Tilanus-Linthorst MM, Obdeijn IM, Hop WC, Causer PA, Leach MO, Warner E, Pointon L, Hill K, Klijn JG, Warren RM, et al: BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials. Clin Cancer Res. 2007, 13 (24): 7357-7362. 10.1158\/1078-0432.CCR-07-0689.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3332_CR25","doi-asserted-by":"publisher","first-page":"W292","DOI":"10.2214\/AJR.10.6049","volume":"198","author":"CM Checka","year":"2012","unstructured":"Checka CM, Chun JE, Schnabel FR, Lee J, Toth H: The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol. 2012, 198 (3): W292-W295. 10.2214\/AJR.10.6049.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"3332_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1148\/radiology.213.2.r99nv05413","volume":"213","author":"HM Zonderland","year":"1999","unstructured":"Zonderland HM, Coerkamp EG, Hermans J, van de Vijver MJ, van Voorthuisen AE: Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology. 1999, 213 (2): 413-422.","journal-title":"Radiology"},{"issue":"1","key":"3332_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/1055-9965.EPI-03-0090","volume":"13","author":"CJ van Asperen","year":"2004","unstructured":"van Asperen CJ, Jonker MA, Jacobi CE, van Diemen-Homan JE, Bakker E, Breuning MH, van Houwelingen JC, de Bock GH: Risk estimation for healthy women from breast cancer families: new insights and new strategies. Cancer Epidemiol Biomarkers Prev. 2004, 13 (1): 87-93. 10.1158\/1055-9965.EPI-03-0090.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3332_CR28","unstructured":"Familial breast cancer: the classification and care of women at risk of famial breast cancer in primary, secondary and tertiary care. Clinical Guideline 14. http:\/\/www.nice.org.uk\/nicemedia\/live\/10994\/30247\/30247.pdf ,"},{"issue":"7","key":"3332_CR29","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00330-008-0863-7","volume":"18","author":"RM Mann","year":"2008","unstructured":"Mann RM, Kuhl CK, Kinkel K, Boetes C: Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 2008, 18 (7): 1307-1318. 10.1007\/s00330-008-0863-7.","journal-title":"Eur Radiol"},{"key":"3332_CR30","unstructured":"ACR practice guideline for the performance of contrastenhanced magnetic resonance imaging (MRI) of the breast. http:\/\/www.acr.org\/SecondaryMainMenuCategories\/quality_safety\/guidelines\/breast\/mri_breast.aspx ],"},{"issue":"5","key":"3332_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, et al: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004, 351 (5): 427-437. 10.1056\/NEJMoa031759.","journal-title":"N Engl J Med"},{"issue":"33","key":"3332_CR32","doi-asserted-by":"publisher","first-page":"8469","DOI":"10.1200\/JCO.2004.00.4960","volume":"23","author":"CK Kuhl","year":"2005","unstructured":"Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W, Schild HH: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005, 23 (33): 8469-8476. 10.1200\/JCO.2004.00.4960.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3332_CR33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","volume":"148","author":"E Warner","year":"2008","unstructured":"Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D: Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 2008, 148 (9): 671-679.","journal-title":"Ann Intern Med"},{"issue":"9586","key":"3332_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(07)61232-X","volume":"370","author":"CK Kuhl","year":"2007","unstructured":"Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, Kuhn W, Schild HH: MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007, 370 (9586): 485-492. 10.1016\/S0140-6736(07)61232-X.","journal-title":"Lancet"},{"issue":"6","key":"3332_CR35","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1471-0528.2008.01690.x","volume":"115","author":"AL Eilertsen","year":"2008","unstructured":"Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM: Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method. BJOG. 2008, 115 (6): 773-779. 10.1111\/j.1471-0528.2008.01690.x.","journal-title":"BJOG"},{"issue":"3","key":"3332_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1109\/TMI.2005.862741","volume":"25","author":"S van Engeland","year":"2006","unstructured":"van Engeland S, Snoeren PR, Huisman H, Boetes C, Karssemeijer N: Volumetric breast density estimation from full-field digital mammograms. IEEE Trans Med Imaging. 2006, 25 (3): 273-282.","journal-title":"IEEE Trans Med Imaging"},{"issue":"2","key":"3332_CR37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1064-9689(21)00080-5","volume":"9","author":"C Boetes","year":"2001","unstructured":"Boetes C, Stoutjesdijk M: MR imaging in screening women at increased risk for breast cancer. Magn Reson Imaging Clin N Am. 2001, 9 (2): 357-372. vii","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"8","key":"3332_CR38","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/annonc\/mdg319","volume":"14","author":"HJ de Koning","year":"2003","unstructured":"de Koning HJ: Mammographic screening: evidence from randomised controlled trials. Ann Oncol. 2003, 14 (8): 1185-1189. 10.1093\/annonc\/mdg319.","journal-title":"Ann Oncol"},{"issue":"2","key":"3332_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/sj.bjc.6601520","volume":"90","author":"JH Groenewoud","year":"2004","unstructured":"Groenewoud JH, Pijnappel RM, van den Akker-Van Marle ME, Birnie E, Buijs-van der Woude T, Mali WP, de Koning HJ, Buskens E: Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy. Br J Cancer. 2004, 90 (2): 383-392. 10.1038\/sj.bjc.6601520.","journal-title":"Br J Cancer"},{"issue":"5","key":"3332_CR40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.20143","volume":"110","author":"AJ Rijnsburger","year":"2004","unstructured":"Rijnsburger AJ, van Oortmarssen GJ, Boer R, Draisma G, To T, Miller AB, de Koning HJ: Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation. Int J Cancer. 2004, 110 (5): 756-762. 10.1002\/ijc.20143.","journal-title":"Int J Cancer"},{"key":"3332_CR41","volume-title":"National evaluation of breast cancer screening in the Netherlands - eleventh evaluation report","author":"(NETB) NETfBcs","year":"2005","unstructured":"(NETB) NETfBcs: National evaluation of breast cancer screening in the Netherlands - eleventh evaluation report. 2005, Department of Public Health, Erasmus MC, Rotterdam"},{"issue":"17","key":"3332_CR42","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1056\/NEJMoa050518","volume":"353","author":"DA Berry","year":"2005","unstructured":"Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ, et al: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005, 353 (17): 1784-1792. 10.1056\/NEJMoa050518.","journal-title":"N Engl J Med"},{"issue":"10","key":"3332_CR43","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/cncr.11361","volume":"97","author":"N Bjurstam","year":"2003","unstructured":"Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Hafstrom LO, et al: The Gothenburg Breast Screening Trial. Cancer. 2003, 97 (10): 2387-2396. 10.1002\/cncr.11361.","journal-title":"Cancer"},{"issue":"9310","key":"3332_CR44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","volume":"359","author":"L Nystrom","year":"2002","unstructured":"Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE: Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002, 359 (9310): 909-919. 10.1016\/S0140-6736(02)08020-0.","journal-title":"Lancet"},{"issue":"9367","key":"3332_CR45","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(03)13143-1","volume":"361","author":"L Tabar","year":"2003","unstructured":"Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW: Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003, 361 (9367): 1405-1410. 10.1016\/S0140-6736(03)13143-1.","journal-title":"Lancet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-440.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-440\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T22:13:24Z","timestamp":1643494404000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3332"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-440","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,2]]},"article-number":"440"}}